Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit

SALT LAKE CITY, Oct. 13, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today its participation in the upcoming 2025 Maxim Growth Summit, taking place October 22-23 at The Hard Rock Hotel NYC.

Read more at prnewswire.com